Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142339 |
| CAS No | NA |
| Mol.F. | C13H8N2O2 |
| Mol.Wt. | 224.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142340 |
| CAS No | NA |
| Mol.F. | C21H18N4O6S2 |
| Mol.Wt. | 486.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142341 |
| CAS No | NA |
| Mol.F. | C12H17N3O5S |
| Mol.Wt. | 315.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142342 |
| CAS No | NA |
| Mol.F. | C7H9N3O4S |
| Mol.Wt. | 231.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142343 |
| CAS No | NA |
| Mol.F. | C24H23N3O6 |
| Mol.Wt. | 449.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142344 |
| CAS No | NA |
| Mol.F. | C17H17N3O5 |
| Mol.Wt. | 343.34 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142345 |
| CAS No | NA |
| Mol.F. | C18H19N3O5 |
| Mol.Wt. | 357.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142346 |
| CAS No | NA |
| Mol.F. | C12H12Cl2N4O3 |
| Mol.Wt. | 331.15 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142347 |
| CAS No | NA |
| Mol.F. | C11H10Cl2N4O3 |
| Mol.Wt. | 317.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142348 |
| CAS No | NA |
| Mol.F. | C10H5Cl3N4O2 |
| Mol.Wt. | 319.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142349 |
| CAS No | NA |
| Mol.F. | C10H6Cl2N4O3 |
| Mol.Wt. | 301.08 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142350 |
| CAS No | NA |
| Mol.F. | C11H10Cl3N3O5 |
| Mol.Wt. | 370.57 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142351 |
| CAS No | NA |
| Mol.F. | C8H6Cl2N4O |
| Mol.Wt. | 245.06 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142352 |
| CAS No | NA |
| Mol.F. | C11H14ClN3O3 |
| Mol.Wt. | 271.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142353 |
| CAS No | NA |
| Mol.F. | C21H19N3O8 |
| Mol.Wt. | 441.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142354 |
| CAS No | NA |
| Mol.F. | C58H72N8O18 |
| Mol.Wt. | 1169.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |